179 related articles for article (PubMed ID: 31691080)
21. An acute herb-drug interaction of Magnoliae Officinalis Cortex with methotrexate via inhibiting multidrug resistance-associated protein 2.
Yu CP; Li PY; Chen SY; Lin SP; Chen YC; Ho LC; Hsieh YW; Hou YC
J Food Drug Anal; 2024 Mar; 32(1):103-111. PubMed ID: 38526588
[TBL] [Abstract][Full Text] [Related]
22. Effect of JBP485 on obstructive jaundice is related to regulation of renal Oat1, Oat3 and Mrp2 expression in ANIT-treated rats.
Liu T; Guo X; Meng Q; Wang C; Liu Q; Sun H; Ma X; Kaku T; Liu K
Peptides; 2012 Jul; 36(1):78-85. PubMed ID: 22521734
[TBL] [Abstract][Full Text] [Related]
23. Renal Drug Transporters and Drug Interactions.
Ivanyuk A; Livio F; Biollaz J; Buclin T
Clin Pharmacokinet; 2017 Aug; 56(8):825-892. PubMed ID: 28210973
[TBL] [Abstract][Full Text] [Related]
24. Renal expression of organic anion transporters is modified after mercuric chloride exposure: Gender-related differences.
Hazelhoff MH; Bulacio RP; Chevalier A; Torres AM
Toxicol Lett; 2018 Oct; 295():390-396. PubMed ID: 30031051
[TBL] [Abstract][Full Text] [Related]
25. Methotrexate-vindesine association in head and neck cancer: modification of methotrexate's hydroxylation in presence of vindesine.
Bore P; Lena N; Imbert AM; Favre R; Cano JP; Meyer G; Carcassonne Y
Cancer Chemother Pharmacol; 1986; 17(2):171-6. PubMed ID: 3719898
[TBL] [Abstract][Full Text] [Related]
26. JBP485 attenuates vancomycin-induced nephrotoxicity by regulating the expressions of organic anion transporter (Oat) 1, Oat3, organic cation transporter 2 (Oct2), multidrug resistance-associated protein 2 (Mrp2) and P-glycoprotein (P-gp) in rats.
Wen S; Wang C; Huo X; Meng Q; Liu Z; Yang S; Zhu Y; Sun H; Ma X; Liu K
Toxicol Lett; 2018 Oct; 295():195-204. PubMed ID: 29964132
[TBL] [Abstract][Full Text] [Related]
27. Risk factors for high-dose methotrexate associated toxicities in patients with primary central nervous system lymphoma.
Sun K; Tao H; Ding T; Li Z; Qiu X; Zhong M; Wu Z
J Clin Pharm Ther; 2022 Dec; 47(12):2196-2204. PubMed ID: 36259502
[TBL] [Abstract][Full Text] [Related]
28. MDR1 and OAT1/OAT3 mediate the drug-drug interaction between puerarin and methotrexate.
Liu Q; Wang C; Meng Q; Huo X; Sun H; Peng J; Ma X; Sun P; Liu K
Pharm Res; 2014 May; 31(5):1120-32. PubMed ID: 24242937
[TBL] [Abstract][Full Text] [Related]
29. Ex vivo resistance in childhood acute lymphoblastic leukemia: Correlations between BCRP, MRP1, MRP4 and MRP5 ABC transporter expression and intracellular methotrexate polyglutamate accumulation.
Jaramillo AC; Cloos J; Lemos C; Stam RW; Kaspers GJL; Jansen G; Peters GJ
Leuk Res; 2019 Apr; 79():45-51. PubMed ID: 30849662
[TBL] [Abstract][Full Text] [Related]
30. In vitro transport of gimatecan (7-t-butoxyiminomethylcamptothecin) by breast cancer resistance protein, P-glycoprotein, and multidrug resistance protein 2.
Marchetti S; Oostendorp RL; Pluim D; van Eijndhoven M; van Tellingen O; Schinkel AH; Versace R; Beijnen JH; Mazzanti R; Schellens JH
Mol Cancer Ther; 2007 Dec; 6(12 Pt 1):3307-13. PubMed ID: 18089724
[TBL] [Abstract][Full Text] [Related]
31. Developmental expression of renal organic anion transporters in rat kidney and its effect on renal secretion of phenolsulfonphthalein.
Nomura M; Motohashi H; Sekine H; Katsura T; Inui K
Am J Physiol Renal Physiol; 2012 Jun; 302(12):F1640-9. PubMed ID: 22419695
[TBL] [Abstract][Full Text] [Related]
32. Transport properties of valsartan, sacubitril and its active metabolite (LBQ657) as determinants of disposition.
Hanna I; Alexander N; Crouthamel MH; Davis J; Natrillo A; Tran P; Vapurcuyan A; Zhu B
Xenobiotica; 2018 Mar; 48(3):300-313. PubMed ID: 28281384
[TBL] [Abstract][Full Text] [Related]
33. Regulatory guidelines do not accurately predict tolvaptan and metabolite interactions at BCRP, OATP1B1, and OAT3 transporters.
Shoaf SE; Bricmont P; Repella Gordon J
Clin Transl Sci; 2021 Jul; 14(4):1535-1542. PubMed ID: 33742787
[TBL] [Abstract][Full Text] [Related]
34. The key role of organic anion transporter 3 in the drug-drug interaction between tranilast and methotrexate.
Wang J; Yuan W; Shen Q; Wu Q; Jiang Z; Wu W; Zhang L; Huang X
J Biochem Mol Toxicol; 2022 Apr; 36(4):e22983. PubMed ID: 35019195
[TBL] [Abstract][Full Text] [Related]
35. The effect of vindesine on methotrexate hydroxylation in the rat.
Bremnes RM; Smeland E; Slørdal L; Wist E; Aarbakke J
Biochem Pharmacol; 1991 Sep; 42(8):1561-8. PubMed ID: 1930283
[TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetic changes of cefdinir and cefditoren and its molecular mechanisms in acute kidney injury in rats.
Wang H; Sun P; Wang C; Meng Q; Liu Z; Huo X; Sun H; Ma X; Peng J; Liu K
J Pharm Pharmacol; 2018 Nov; 70(11):1503-1512. PubMed ID: 30047127
[TBL] [Abstract][Full Text] [Related]
37. Methotrexate-vindesine association in leukemia: pharmacokinetic study.
Tubiana N; Lena N; Barbet J; Imbert AM; Lejeune C; Maraninchi D; Sainty D; Sebahoun G; Gastaut JA; Cano JP
Med Oncol Tumor Pharmacother; 1985; 2(2):99-102. PubMed ID: 3864001
[TBL] [Abstract][Full Text] [Related]
38. Risk of Hematologic Events With Coadministration of Methotrexate and the Breast Cancer Resistance Protein Inhibitor Febuxostat.
Mitsuboshi S; Niimura T; Kanda M; Ishida S; Zamami Y; Ishizawa K
Ann Pharmacother; 2022 Aug; 56(8):910-915. PubMed ID: 34726078
[TBL] [Abstract][Full Text] [Related]
39. Effect of lycopene against cisplatin-induced acute renal injury in rats: organic anion and cation transporters evaluation.
Erman F; Tuzcu M; Orhan C; Sahin N; Sahin K
Biol Trace Elem Res; 2014 Apr; 158(1):90-5. PubMed ID: 24531880
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of the endothelin receptor antagonists ambrisentan, bosentan, macitentan, and sitaxsentan as hepatobiliary transporter inhibitors and substrates in sandwich-cultured human hepatocytes.
Lepist EI; Gillies H; Smith W; Hao J; Hubert C; St Claire RL; Brouwer KR; Ray AS
PLoS One; 2014; 9(1):e87548. PubMed ID: 24498134
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
